Because of high costs, Blue Cross Blue Shield of Massachusetts plans to end coverage for Wegovy, Saxenda, and Zepbound starting in 2026
By Jen Murphy and Theodore Tae Is coffee dehydrating
Among firms that offer health benefits with 200 or more workers, 16% of firms with 200 to 999 workers, 30% of firms with 1,000 to 4,999 workers, and 43% of firms with 5,000 or more workers cover GLP-1 agonists when used primarily for weight loss in 2025
While we focus on radiance and tone, not dramatic skin whitening claims, the improvements in skin health are undeniable
Building genuine, lasting relationships with faith leaders and groups presents a promising approach for better listening to communities and for sharing scientific information with trusted messengers who could be influential in health decisions
This raises peri-procedural concerns regarding anesthesia/pulmonary aspiration risks, poor visibility, and the need for repeat procedures, all of which contribute to significant time, cost, and resource utilization burden